What this trial measures

• Number of participants with improved estimation of Trials to Criterion and Time (days) to Criterionthrough study completion, expected to be 18 months from the start of retroactive observation period

  Does Acuity make initial timeline estimates for sets of targets more accurate?

• Increased frequency of changes to programs and prescribed dosages, resulting in reduced Trials to Criterion and Time to Criterion.through study completion, expected to be 18 months from the start of retroactive observation period

  Does Acuity result in corrective action being taken more quickly for programs that are off schedule or targets that are exhibiting performance issues?

• Increased adherence to prescribed dosagethrough study completion, expected to be 18 months from the start of retroactive observation period

  Does Acuity result in increased adherence to prescribed dosage, as measured by system

• Number of participants who find Acuity and its components practical and possible to use, assessed by qualitative measures and system usage trackingat the end of the study, expected to be 18 months from the start of retroactive observation period

  Feasibility - To what extent are Acuity and its components practical or possible to use?

• Proportion of clinics and providers that actively use Acuity, assessed by system usage tracking.at the end of the study, expected to be 18 months from the start of retroactive observation period

  Adoption - What proportion of clinics and providers are willing to use Acuity and how well do they represent the population of clinics and providers?

• Number of BAs & BTs who utilize Acuity as intended to provide learners with accurate treatment plans, and achieve expected results, as measured by system usage and qualitative assessment.at the end of the study, expected to be 18 months from the start of retroactive observation period

  Fidelity - the degree to which BAs and BTs use the system as expected, including dosage adherence, treatment planning accuracy, and timely protocol modification.

• Majority of BAs and BTs rate Acuity and its components as attractive, agreeable, or palatable.at the end of the study, expected to be 18 months from the start of retroactive observation period

  Acceptability, as measured by SUS score and SUS Items 1, 5, 6 \& 8 collected via online survey at the end of O0 \& O1 from both arms.

• Frequency at which Acuity and its components are rated as suitable, fitting, or proper for achieving the goals set forth in treatment plans, as measured by surveys.at the end of the study, expected to be 18 months from the start of retroactive observation period

  Appropriateness - Same measures captured for all primary \& secondary research questions in the Functional Impact Evaluation. Brief online survey with Likert scaled items focused on the providers' assessment of how well Acuity and its components are matched to the challenges of planning and executing Treatment Plans.